Through CCK-8, wound healing, transwell, and cell adhesion assays, it was confirmed that overexpressing AKR1B10 could dramatically inhibit cell viability, migration, invasion, and adhesion of GC cells, which further supported results in previous research. Here, AKR1B10 is linked to gastric cancer.